Sucralfate
Cat. No.：YN251113
CAS No. ：54182-58-0
| 产品名称: | Sucralfate |
| CAS No.: | 54182-58-0 |
| Chemical Name: | hexadeca-μ-hydroxytetracosahydroxy[μ8-[[1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl α-D-glucopyranoside tetrakis(sulfato-κO')](8-)]]hexadeca-aluminum |
| Synonyms: | 硫糖铝; Sucrose octasulfate-aluminum complex |
| 分子量: | 2046.42 |
| 分子式: | C₁₂H₁₄Al₁₆O₇₅S₈ |
| SMILES: | [OSO3[Al2(OH5)]][C@H]([C@@H](C[OSO3[Al2(OH5)]])O1)[C@H](O[S]=O=O=O=[OH5]#[Al]#[Al])[C@]1(C[OSO3[Al2(OH5)]])O[C@@H]2[C@H](O[S]=O=O=O=[OH5]#[Al]#[Al])[C@H](O[S]=O=O=O=[OH5]#[Al]#[Al])[C@H](O[S]=O=O=O=[OH5]#[Al]#[Al])[C@@H](C[OSO3[Al2(OH5)]])O2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Sucralfate (Sucrose octasulfate-aluminum complex) 是一种有效的口服活性胃保护剂 (gastroprotectant)，无全身性影响。Sucralfate 抑制消化性活性，并与黏膜损伤时暴露的带负电荷的上皮下蛋白结合，形成一层粘性层，保护血管床和增殖区。Sucralfate 在体内用于预防和治疗胃肠道疾病。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Borella, L.E., Seethaler, K., and Lippmann, W.Sucralfate: Antipeptic, antiulcer activities and antagonism of gastric emptyingArzneimittelforschung29(5),793-798(1979)
Harrington, S.J., Schlegel, J.F., and Code, C.F.The protective effect of sucralfate on the gastric mucosa of ratsJ. Clin. Gastroenterol.3(Suppl 2),129-134(1981)
